Sun02172019

Robins Global News & Noticias



  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: Global Blood Therapeutics Announces Proposed Public Offering of Common Stock


SOUTH SAN FRANCISCO, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities, today announced an agreement to sell $150.0 million in shares of its common stock in a registered underwritten public offering.  In addition, GBT has granted the underwriter a 30-day option to purchase up to $22.5 million in shares of its common stock.
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.GBT intends to use the net proceeds from the offering and its existing capital resources to fund its clinical development of voxelotor for the treatment of sickle cell disease, including its ongoing clinical studies, as well as preparation for the potential commercial launch of voxelotor, if approved by the U.S. Food and Drug Administration, future clinical trials of voxelotor and other product candidates that GBT may elect to pursue, including inclacumab, its other research and development activities, and for working capital and general corporate purposes. GBT may also use a portion of the net proceeds to in-license, acquire or invest in new business, technology or assets, although it has no material agreements, commitments or understandings in place.An automatic shelf registration statement relating to the shares of common stock offered in the public offering described above was filed with the Securities and Exchange Commission (SEC) on August 23, 2017 and automatically became effective upon filing. The securities may be offered only by means of a written prospectus, including a prospectus supplement, forming a part of the effective registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. When available, copies of the preliminary prospectus supplement and the accompanying prospectus may also be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Ave., 6th Floor, New York, New York 10022, or by email at This email address is being protected from spambots. You need JavaScript enabled to view it..This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.About GBT


Posted: 2018-12-06 21:05:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.






Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: Global Blood Therapeutics Announces Proposed Public Offering of Common Stock | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

Reed’s Inc. Prices Underwritten Public Offering of Common Stock

Fri, 15 Feb 2019 05:16:00 GMT

Reed's Inc. Prices Underwritten Public Offering of Common Stock NORWALK ... A shelf registration statement relating to the shares of common stock to be issued in the proposed offering was filed with t...

Achaogen Announces Proposed Public Offering of Common Stock

Thu, 14 Feb 2019 13:12:00 GMT

In addition, Achaogen expects to grant the underwriter of the offering a 30-day option to purchase additional shares of common stock at the ... of proceeds of the proposed public offering.

Reed’s Inc. Announces Proposed Public Offering of Common Stock

Thu, 14 Feb 2019 13:10:00 GMT

February 14, 2019 16:05 ET | Source: Reed's Inc. NORWALK, Conn., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Reed’s Inc. (NYSE American: REED), owner of the nation’s leading portfolio of handcrafted ...

HubSpot Announces Proposed Public Offering of Common Stock

Wed, 13 Feb 2019 14:20:00 GMT

CAMBRIDGE, Mass., Feb. 13, 2019 /PRNewswire/ -- HubSpot, Inc. ("HubSpot") (HUBS), a leading growth platform, today announced that it has commenced an underwritten public offering of 1.7 million ...

MacroGenics Announces Proposed Public Offering of Common Stock

Tue, 12 Feb 2019 13:12:00 GMT

MacroGenics, Inc. (MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today ...

Related Bing Web Search

  • No items found
  • Related News Story Videos From Youtube

    Common Stock Offerings Explained – Lesson On How It Relates To PENNY STOCKS – Tesla $250M Offering


    Related Videos On: Common Stock Offerings Explained – Lesson On How It Relates To PENNY STOCKS – Tesla $250M Offering


    Public offerings secondary offerings shelf offerings stock market


    Related Videos On: Public offerings secondary offerings shelf offerings stock market


    How an Initial Public Offering (IPO) Works


    Related Videos On: How an Initial Public Offering (IPO) Works


    Public Offering Of Common Stock


    Related Videos On: Public Offering Of Common Stock


    Stock dilution | Stocks and bonds | Finance & Capital Markets | Khan Academy


    Related Videos On: Stock dilution | Stocks and bonds | Finance & Capital Markets | Khan Academy






    Blow Us A Whistle

    Comments (Whistles) Designed By Disqus




    Company Information

    Official Content Providers











    PRIVACY POLICY

    We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
    © 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
    RobinsPost provides links to news sites based on their RSS feeds.
    All trademarks, copyrights, videos, photos and logos are owned by news sources.
    News stories, videos and live streams are from trusted sources.
    ROBINSPOST Is Proudly Made In America.
    Where Quality, Safety and Service Comes First.